Serum homocysteine levels and paraoxonase 1 activity in preschool aged children in Greece

Clinical Chemistry and Laboratory Medicine

Volumn 44, Issue 5, 2006, Pages 623-627

  Karikas, George A ^a   Kriebardis, Anastasios ^a   Samara, Ioanna ^b   Schulpis, Kleopatra ^c   Papachristodoulou, Maria ^a   Fytou Pallikari, Athena ^a  

^a UNIVERSITY OF WEST ATTICA   (Greece)

^b Sotiria University Hospital   (Greece)

^c AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

Age; Cardiovascular disease; Children; Homocysteine; Paraoxonase; Sex

Indexed keywords

ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE 1; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE;

AMINO ACID BLOOD LEVEL; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CORRELATION COEFFICIENT; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; GENETIC RISK; GREECE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHYLATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCREENING; SYSTOLIC BLOOD PRESSURE; THROMBOEMBOLISM; VENOUS THROMBOEMBOLISM;

ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; CHILD; CHILD, PRESCHOOL; FEMALE; GREECE; HOMOCYSTEINE; HUMANS; LIPOPROTEINS, HDL; MALE; REFERENCE VALUES; SEX FACTORS; SPECTROPHOTOMETRY;

EID: 33646691052     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2006.110     Document Type: Article

References (31)

1. Malinow MR, Kang SS, Taylor LM, Wong PW. Prevalence I hyperhomocysteinemia in patients with peripheral arterial occlusive disease. Circulation 1989;79:1180-8.
2. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969;56:111-28.
3. Bouchey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. J Am Med Assoc 1995;274:1049-57.
4. The European Concerted Action Project. Plasma homocysteine as a risk factor for vascular disease. J Am Med Assoc 1997;277:1775-81.
5. Nygard O, Nordrehang JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;337:230-6.
6. Frosst P, Blom HJ, Milos R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.
7. 12 and folate status on plasma homocysteine in children. Am J Clin Nutr 2000;72:1469-73.
8. van der Mooren MJ, Wouters MG, Blom HJ, Schellekens LA, Eskes TK, Rolland R. Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women. Eur J Clin Invest 1994;24:733-6.
9. Schulpis KH, Karikas GA, Papakonstantinou E. Homocysteine and other vascular risk factors in patients with phenylketonuria on a diet. Acta Paediatr 2002;91:905-9.
10. Osganian SK, Stampfer MJ, Spiegelman D, Rimm E, Cutler JA, Feldmam HA, et al. Distribution of and factors associated with serum Hcy levels in children: Child and Adolescent Trial for Cardiovascular Health. J Am Med Assoc 1999;281:1189-96.
11. Tonstad S, Refsum H, Sivertsen M, Christophersen B, Ose L, Ueland PM. Relation of total homocysteine and lipid levels in children to premature cardiovascular death in male relatives. Pediatr Res 1996;40:47-52.
12. Vilaseca MA, Moyano D, Ferrer I, Artuch R. Total Hcy in pediatric patients. Clin Chem 1997;43:690-2.
13. Kahn A. Plasma Hcy concentration in a Belgian school-age population. Am J Clin Nutr 1999;69:968-72.
14. Must A, Jacques PF, Rogers G, Rosemberg IH, Selhub J. Serum total homocysteine concentrations in children and adolescents: results from the Third National Health and Nutrition Examination Survey (NHANES III) J Nutr 2003;133:2643-9.
15. Valabhji J, McCall AJ, Schachter M, Dhanjil S, Richmond W, Elkeles RS. High density lipoprotein composition and paraoxonase activity in type I diabetes. Clin Sci 2001;101:659-70.
16. Mackness B, Durrington PN, Boulton AJ, Hine D, Mackness MI. Serum paraoxonase activity in patients with type I diabetes compared to healthy controls. Eur J Clin Invest 2002;32:259-64.
17. Durrington PN, Mackness B, Mackness MI. Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 2001;21:473-80.
18. Jakubowski H. Calcium-dependent human serum homocysteine thiolactone hydrolase. J Biol Chem 2000;275:3957-62.
19. Rosenblat M, Grunfeld O, Hayek T, Aviram M. Serum paraoxonase activity and the extent of lipid peroxidation are not affected by increased levels of human apolipoprotein A-I: studies in transgenic mice. Clin Chem Lab Med 2002;40:9-14.
20. Pernet P, Lasnier E, Vaubourdolle M. Evaluation of the AxSYM homocysteine assay and comparison with the IMX homocysteine assay. Clin Chem 2000;46:1440-1.
21. Chimonas ET. The treatment of coronary heart disease; an update. Part 2. Mortality trends and main causes of death in the Greek population. Curr Med Res Opin 2001;17:27-33.
22. Ueland PM, Borke Monsen AL. Hyperhomocysteinemia and B-vitamin deficiencies in infants and children. Clin Chem Lab Med 2003;41:1418-26.
23. Bates CJ, Mansoor MA, Gregory J, Pentiev K, Prentice A. Correlates of plasma homocysteine, cysteine and cysteinyl-glycine in respondents in the British National Diet and Nutrition Survey of young people aged 4-18 years, and a comparison with the survey of people aged 65 years and over. Br J Nutr 2002;87:71-9.
24. Refsum H, Grindflek AW, Ueland PM, Fredriksen E, Meyer K, Ulvik A, et al. Screening for serum total homocysteine in newborn children. Clin Chem 2004;50:1769-84.
25. Reddy MN. Reference ranges for total homocysteine in children. Clin Chim Acta 1997;262:153-5.
26. De Laet C, Wautrecht JC, Brasseur D, Dramaix M, Boeynaems JM, Decuyper J, et al. Plasma homocysteine concentration in a Belgian school-age population. Am J Clin Nutr 1999;69:968-72.
27. Tonstad S, Refsum H, Ueland PM. Association between plasma total homocysteine and parental history of cardiovascular disease in children with familial hypercholesterolemia. Circulation 1997;96:1803-8.
28. Dedousis GV, Panagiotakos DB, Chrysohoou C, Pitsavos C, Zampelas A, Choumerianou D, et al. Effect of interaction between adherence to a Mediterranean diet and the methylenetetrahydrofolate reductase 677C > T mutation on homocysteine concentrations in healthy adults: the ATTICA Study. Am J Clin Nutr 2004;80:849-54.
29. Papoutsakis C, Yiannakouris N, Manios Y, Papaconstantinou E, Magkos F, Schulpis KH, et al. Plasma homocysteine concentrations in Greek children are influenced by an interaction between the methylenetetrahdrofolate reductase C677T genotype and folate status. J Nutr 2005;135:383-8.
30. Kark JD, Sinnreich R, Rosenberg IH, Jacques PF, Selhub J. Plasma homocysteine and parental myocardial infarction in young adults in Jerusalem. Circulation 2002;105:2725-9.
31. Hogeveen M, Blom HJ, Van Amerongen M, Boogmans B, Van Beynum IM, Van De Bor M. Hyperhomocysteinemia as risk factor for ischemic and hemorrhagic stroke in new-born infants. J Pediatr 2002;141:429-31.